Literature DB >> 24981038

Primary immunodeficiency diseases: a 30-year patient registry from the referral center for primary immunodeficiencies in Greece.

Athanasios Michos1, Maria Raptaki, Sofia Tantou, Marianna Tzanoudaki, Kleopatra Spanou, Manolis Liatsis, Nikki Constantinidou, Evangelia Paschali, Ioanna Varela, Olga Moraloglou, Chryssa Bakoula, Maria Kanariou.   

Abstract

Primary Immunodeficiencies (PID) represent a group of heterogeneous immune diseases with important biological significance. We reviewed the records of children diagnosed with PID in the Referral Center for PID in our country in order to describe the epidemiological, clinical and laboratory characteristics of immunodeficient patients. During a 30-year period, 147 patients (101 males, 68.7 %), with a mean age of 6.5 years at the time of diagnosis, were diagnosed with PID. The most prevalent diagnoses of PID were: "Combined Immunodeficiency" in 46 (31.3 %) patients, "Well-defined immunodeficiency syndrome" in 35 (23.1 %) patients, "Predominantly antibody deficiency" in 30 (20.4 %) patients and "Congenital defect of phagocyte function or both" in 28 (19 %) patients. There was a higher prevalence of males with "Combined immunodeficiency" (p < 0.033) and "Predominantly antibody deficiency" (p < 0.02) compared to females. The median age of children at the onset of symptoms and at the time of diagnosis was 0.5y (IQR: 0.1-2.5) and 2y (IQR: 0.6-7.2), respectively. The median diagnostic delay was 0.9y (IQR: 0.2-4.8). This period was shorter for patients with "Combined immunodeficiency" [median 0.3y (IQR: 0.1-1)], and longer for those with "Predominantly antibody deficiency" [median 3.2y (IQR: 0.2-5.9) or "Disease of immune dysregulation" [median 3.2y (IQR: 0.1-6.6)]. Comparing the rates in our population with those of the European Registry (ESID), the rates of "Combined immunodeficiencies", "Well-defined syndromes" and "Congenital birth defects and/or function of phagocytes" were significantly higher in this study (p <0,001). PID registry analysis improves knowledge in the field of Immunology and enhances awareness, early detection, diagnosis, and management of this rare but significant group of diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24981038     DOI: 10.1007/s10875-014-0066-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  35 in total

1.  The incidence of primary immunodeficiency syndromes in Israel.

Authors:  Hana Golan; Ilan Dalal; Ben-Zion Garty; Menachem Schlesinger; Jacob Levy; Zeev Handzel; Baruch Wolach; Menachem Rottem; Arnon Goldberg; Rami Tamir; Ariel Koren; Yael Levy; Yitzhak Katz; Justine Passwell; Amos Etzioni
Journal:  Isr Med Assoc J       Date:  2002-11       Impact factor: 0.892

2.  Population prevalence of diagnosed primary immunodeficiency diseases in the United States.

Authors:  J M Boyle; R H Buckley
Journal:  J Clin Immunol       Date:  2007-06-19       Impact factor: 8.317

3.  The French national registry of primary immunodeficiency diseases.

Authors: 
Journal:  Clin Immunol       Date:  2010-05       Impact factor: 3.969

Review 4.  Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

5.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

6.  Incidence and temporal trends of primary immunodeficiency: a population-based cohort study.

Authors:  Avni Y Joshi; Vivek N Iyer; John B Hagan; Jennifer L St Sauver; Thomas G Boyce
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

Review 7.  Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece.

Authors:  Maria Raptaki; Ioanna Varela; Kleopatra Spanou; Marianna Tzanoudaki; Sofia Tantou; Manolis Liatsis; Nikki Constantinidou; Chryssa Bakoula; Dirk Roos; Maria Kanariou
Journal:  J Clin Immunol       Date:  2013-10-01       Impact factor: 8.317

8.  Primary immunodeficiency diseases in Egyptian children: a single-center study.

Authors:  Shereen M Reda; Hanaa M Afifi; Mai M Amine
Journal:  J Clin Immunol       Date:  2008-11-11       Impact factor: 8.317

9.  Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.

Authors:  Waleed Al-Herz; Aziz Bousfiha; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Alain Fischer; Jose Luis Franco; Raif S Geha; Lennart Hammarström; Shigeaki Nonoyama; Luigi Daniele Notarangelo; Hans Dieter Ochs; Jennifer M Puck; Chaim M Roifman; Reinhard Seger; Mimi L K Tang
Journal:  Front Immunol       Date:  2011-11-08       Impact factor: 7.561

10.  Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004--2006).

Authors:  Waleed Al-Herz
Journal:  J Clin Immunol       Date:  2007-11-16       Impact factor: 8.317

View more
  3 in total

1.  The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules?

Authors:  Petra Lankisch; Julia Schiffner; Sujal Ghosh; Florian Babor; Arndt Borkhardt; Hans-Jürgen Laws
Journal:  J Clin Immunol       Date:  2015-03-08       Impact factor: 8.317

2.  Patient's Experience in Pediatric Primary Immunodeficiency Disorders: Computerized Classification of Questionnaires.

Authors:  Urs Mücke; Christian Klemann; Ulrich Baumann; Almut Meyer-Bahlburg; Xiaowei Kortum; Frank Klawonn; Werner M Lechner; Lorenz Grigull
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

3.  Functional Complement Analysis Can Predict Genetic Testing Results and Long-Term Outcome in Patients With Complement Deficiencies.

Authors:  Štefan Blazina; Maruša Debeljak; Mitja Košnik; Saša Simčič; Sanja Stopinšek; Gašper Markelj; Nataša Toplak; Peter Kopač; Breda Zakotnik; Marko Pokorn; Tadej Avčin
Journal:  Front Immunol       Date:  2018-03-21       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.